Evidence map›Paper›PMID 27034760›Full record

ReviewJournal of clinical and experimental dentistry2016

The role of serum biomarkers in the diagnosis and prognosis of oral cancer: A systematic review.

Ana Fernández-Olavarría, Regina Mosquera-Pérez, Rosa-María Díaz-Sánchez, Maria-Angeles Serrera-Figallo, José-Luis Gutiérrez-Pérez, Daniel Torres-Lagares

Abstract readReview
In one paragraph

Review in Journal of clinical and experimental dentistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Growth differentiation factor 15: a promising biomarker in oral cancer.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Simple and robust polymer-based sensor for rapid cancer detection using serum.Chemical communications (Cambridge, England) · 2019
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Fernández-OlavarríaDDS.School of Dentistry. University of Seville.
Regina Mosquera-PérezDDS.School of Dentistry. University of Seville.
Rosa-María Díaz-SánchezDDS.School of Dentistry. University of Seville.
Maria-Angeles Serrera-FigalloPhD, DDS. School of Dentistry. University of Seville.
José-Luis Gutiérrez-PérezDMD. Professor of Oral Surgery. Chairman of Oral Surgery. Department of Stomatology. University of Seville.
Daniel Torres-LagaresPhD, DDS, MSc (Oral Surgery). Proffesor of Oral Surgery. Department of Stomatology. University of Seville.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOral cancer is one of the causes of major morbidity and mortality in the world although incidence varies in the different geographical locations and races. Advances in molecular biology and cancer research have allowed elucidating serum biomarkers to improve diagnostic methods. The aim of this article systematic review is to highlight the utility and clinical value of serum biomarkers in the diagnosis and prognosis of oral cancer. MATERIAL AND

methodsA systematic literature review using PubMed (MEDLINE databases) revealed a total of 140 articles related to this topic. Of those articles, 29 were included in the final review. We included articles published in English in the last five years, developed in human as cases and controls studies, retrospective or prospective studies and specific studies that analyzed a certain biomarker in serum.

resultsAll of the studies include in this systematic review found significant differences in patients. Of those articles included, 2 used biomarkers to determinate cancerous phenotype, 11 mentioned their results were associated with worse prognosis and overall survival, 4 correlated biomarker concentration to clinical stages, 4 concluded it could be a helpful in diagnosis and 8 studies did not find a clear utility of the analysed biomarker. Due to differences in the presentation of data, meta-analysis was not possible.

conclusionsBiomarker use for diagnosis and prognosis is supported by clinical and scientific evidence is relevant. Nevertheless, after selecting a certain biomarker, monitoring protocols should be established in oral and maxillofacial surgeons teams so as we have a correct understanding of biological values. KEY WORDS: Serum biomarkers, oral cancer, diagnosis, prognosis.

Identifiers

PMID27034760
PMCPMC4808315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.